Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?

Journal of Carcinogenesis

Volumn 4, Issue , 2005, Pages

  Wada, Ryo ^a,b   Ogawa, Kaoru ^a   Yamaguchi, Toshikazu ^c   Tanizaki, Takayuki ^a   Matsumoto, Michio ^a  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c R and D Center   (Japan)

Author keywords

Histogenesis; Intercalated duct; K ras; Molecular analysis; Mucous gland hyperplasia; Pancreatic cancer; PanIN

Indexed keywords

K RAS PROTEIN; KI 67 ANTIGEN; MUCIN 1; MUCIN 6; PROTEIN P53;

ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOPLASM; DNA EXTRACTION; ENZYME IMMUNOASSAY; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICRODISSECTION; MUTATIONAL ANALYSIS; PANCREAS CARCINOMA; PANCREAS CELL; PANCREAS DUCT; PANCREAS ISLET CELL HYPERPLASIA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION;

EID: 26844520788     PISSN: 14773163     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-4-9     Document Type: Article

References (26)

1. Tsuchiya R, Tajima Y, Matsuzaki S, et al.: Early pancreatic cancer. Pancreatology 2001, 1:597-603.
2. Egawa S, Takeda K, Fukuyama S, et al.: Clinicopathological aspects of small pancreatic cancer. Pancreas 2004, 28:235-240.
3. Sommers SC, Murphy SA, Warren S: Pancreatic duct hyperplasia and cancer. Gastroenterology 1954, 27:629-640.
4. Kozuka S, Sassa R, Taki T, et al.: Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979, 43:1418-1428.
5. Chen J, Baithun SI, Ramsay MA: Histogenesis of pancreatic carcinomas: a study based on 248 cases. J Pathol 1985, 146:65-76.
6. Hurban RH, Adsay NV, Albores-Saavedra J, et al.: Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001, 25:579-586.
7. Hruban RH, Wilentz RE, Maitra A: Identification and analysis of precursors to invasive pancreatic cancer. Methods Mol Med 2004, 103:1-14.
8. Kloppel G, Luttges J: The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians. Curr Gastroenterol Rep 2004, 6:111-118.
9. Hruban RH, Takaori K, Klimstra DS, et al.: An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004, 28:977-987.
10. Almoguera C, Shibata D, Forrester K, et al.: Most human carcinomas of exocrine pancreas contain mutant c-K-ras genes. Cell 1988, 53:549-554.
11. Grunnewald K, Lyons J, Frohlich A, et al.: High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989, 43:889-895.
12. Tabata T, Fujimori T, Maeda S, et al.: The role of ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 1993, 14:237-244.
13. Yanagisawa A, Ohtake K, Ohashi K, et al.: Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993, 53:953-956.
14. Matsubayashi H, Watanabe H, Yamaguchi T, et al.: Difference in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of Vater. Cancer 1999, 86:596-607.
15. Wada R, Yamaguchi T: K-ras codon 12 mutations of the superminute dysplasia in Barrett's esophagus by DNA extraction using a microdissection method. Dis Esophagus 2003, 16:214-217.
16. Walters MN: Goblet-cell metaplasia in ductules and acini of the exocrine pancreas. J Pathol Bacteriol 1965, 89:569-572.
17. Pour PM, Sayed S, Sayed G: Hyperplastic preneoplastic, and neoplastic lesions found in 83 human pancreas. Am J Clin Pathol 1982, 77:137-152.
18. Cubilla AL, Fitzgerald PJ: Tumors of the exocrine pancreas. In Atlas of Tumor Pathology, Fascile 19, 2nd Series Armed Forces Institute of Pathology, Washington DC; 1984:71-89.
19. Chambers JA, Hollingsworth MA, Trezise AE, et al.: Development expression of mucin genes MUC1 and MUC2. J Cell Sci 1994, 107:413-424.
20. Terada T, Ohta T, Sasaki M, et al.: Expression of MUC apomucins in normal pancreas and pancreatic tumours. J Pathol 1996, 180:160-165.
21. Masaki Y, Oka M, Ogura Y, et al.: Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma. Hepatogastroenterology 1999, 46:2240-2245.
22. Balague C, Gambus G, Carrato C, et al.: Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. Gastroenterology 1994, 106:1054-1061.
23. Monges GM, Mathoulin-Portier MP, Acres RB, et al.: Differential MUC1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples. Am J Clin Pathol 1999, 112:635-640.
24. Yonezawa S, Horinouchi M, Osako M, et al.: Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with biological behavior of the tumor. Pathol Int 1999, 49:45-54.
25. Scarpa A, Capelli P, Mukai K, et al.: Pancreatic adenocarcinomas frequently show p53 gene mutation. Am J Pathol 1993, 142:1534-1543.
26. Redston MS, Caldas C, Seymour AB, et al.: p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tract in DNA microdeletions. Cancer Res 1994, 54:3025-3033.